Bone Biologics Corporation

8-K Regulation FD disclosure Jul 23, 2026 8-K Other events Jul 16, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 9, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events Mar 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Regulation FD disclosure Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Regulation FD disclosure Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Other events Jun 30, 2025 8-K Other events Jun 26, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 6, 2025 8-K Director or officer change; Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Delisting notice or listing-rule failure Apr 11, 2025 8-K Item 5.08 Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Other events Dec 13, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Director or officer change Oct 21, 2024 8-K Director or officer change Oct 4, 2024 8-K Entered a material agreement Sep 27, 2024 8-K Shareholder vote results Sep 19, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 2, 2024 8-K Regulation FD disclosure Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Director or officer change Mar 15, 2024 8-K Entered a material agreement; Other events Mar 6, 2024 8-K Other events Mar 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Other events Jan 12, 2024 8-K Director or officer change Jan 11, 2024 8-K Other events Jan 10, 2024 8-K Director or officer change Jan 2, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Dec 18, 2023 8-K Shareholder vote results; Other events Dec 13, 2023 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 20, 2023 10-K/A Fiscal year ended 2022-12-31 Nov 20, 2023